Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)
53.00
-0.10 (-0.19%)
May 23, 2025, 2:45 PM CST
SHA:688366 Revenue
Shanghai Haohai Biological Technology had revenue of 618.54M CNY in the quarter ending March 31, 2025, a decrease of -4.25%. This brings the company's revenue in the last twelve months to 2.65B, down -0.65% year-over-year. In the year 2024, Shanghai Haohai Biological Technology had annual revenue of 2.68B with 1.70% growth.
Revenue (ttm)
2.65B
Revenue Growth
-0.65%
P/S Ratio
4.13
Revenue / Employee
1.23M
Employees
2,156
Market Cap
10.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.68B | 44.76M | 1.70% |
Dec 31, 2023 | 2.63B | 504.63M | 23.69% |
Dec 31, 2022 | 2.13B | 380.16M | 21.72% |
Dec 31, 2021 | 1.75B | 425.69M | 32.14% |
Dec 31, 2020 | 1.32B | -271.07M | -16.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |